Herbicidal tetrazole compounds
Novel N-(tetrazol-5-yl)-arylcarboxamide herbicides offer selective weed control by utilizing specific formulations that target weeds while protecting resistant crops, addressing the limitations of existing herbicides.
Patent Information
- Application Number
- JP2023536947
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-12-18
- Filing Date
- 2021-12-15
- Publication Date
- 2025-12-01
- Estimated Expiration
- 2041-12-15
AI Technical Summary
Existing herbicides do not effectively address the need for selective weed control in crops, particularly in plants that are resistant to common herbicides, and there is a lack of formulations that provide efficient and targeted herbicidal compounds.
Development of novel N-(tetrazol-5-yl)-arylcarboxamide compounds and their formulations, including dusts, water-soluble concentrates, wettable powders, and emulsifiable concentrates, which are designed to target weeds while minimizing impact on resistant crop plants.
The compounds provide effective weed control with selective action, allowing for the use in various formulations that enhance application efficacy and reduce non-target effects on crops, including transgenic crops engineered for resistance.
Smart Images

Figure 0007778146000001 
Figure 0007778146000002 
Figure 0007778146000003
Abstract
Description
[Technical Field]
[0001] The present invention relates to novel herbicidal compounds, processes for their preparation, herbicidal compositions containing the novel compounds and their use for controlling weeds or inhibiting plant growth in crops of particularly useful plants. [Background technology]
[0002] N-(tetrazol-5-yl)-arylcarboxamides are disclosed, for example, in WO 2012 / 028579. The present invention relates to novel arylcarboxamides. Summary of the Invention [Means for solving the problem]
[0003] Therefore, according to the present invention, a compound of formula (I): [ka] (In the formula: R 1 is selected from the group consisting of C1-C4 alkyl-, C1-C4 haloalkyl-, C1-C4 alkoxy-C1-C4 alkyl- and C1-C4 haloalkoxy-C1-C4 alkyl-; R 2 is halogen, C1-C6 alkyl-, C1-C3 alkoxy-, C1-C6 haloalkyl- and -S(O) p Selected from the group consisting of C1-C6 alkyl; R 3 is C1-C6 haloalkyl; R 4is selected from the group consisting of C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C1-C3 alkoxy-C1-C3 alkyl-, C3-C6 cycloalkyl-C1-C3 alkyl-, phenyl and heteroaryl, wherein the phenyl or heteroaryl group may, if chemically appropriate, be optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkyl, C1-C3 haloalkoxy and cyano; R 5 is hydrogen or C1-C3 alkyl; and p is 0, 1 or 2 or an agriculturally acceptable salt thereof. DETAILED DESCRIPTION OF THE INVENTION
[0004] Examples of C1-C6 alkyl and C1-C4 alkyl groups include methyl (Me, CH3), ethyl (Et, C2H5), n-propyl (n-Pr), isopropyl (i-Pr), n-butyl (n-Bu), isobutyl (i-Bu), sec-butyl, and tert-butyl (t-Bu).
[0005] C3-C6 cycloalkyl- includes cyclopropyl (c-propyl (c-Pr)), cyclobutyl (c-butyl (c-Bu)), cyclopentyl (c-pentyl), and cyclohexyl (c-hexyl).
[0006] Halogen (or halo) includes fluorine, chlorine, bromine or iodine. The same applies correspondingly to halogen in relation to other definitions, such as haloalkyl.
[0007] Examples of C1 to C6 haloalkyl include fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2,2-difluoroethyl, 1,1-difluoroethyl, 1,1,2,2-tetrafluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1,1-difluoro-2,2,2-trichloroethyl, 2,2,3,3-tetrafluoroethyl, 2,2,2-trichloroethyl, heptafluoro-n-propyl, and perfluoro-n-hexyl. Examples of C1-C4 haloalkyl include fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1,1-difluoro-2,2,2-trichloroethyl, 2,2,3,3-tetrafluoroethyl, 2,2,2-trichloroethyl, and heptafluoro-n-propyl.
[0008] C1-C6 alkyl-S-(alkylthio) is, for example, methylthio, ethylthio, propylthio, isopropylthio, n-butylthio, isobutylthio, sec-butylthio or tert-butylthio, preferably methylthio or ethylthio.
[0009] C1-C6 alkyl-S(O)-(alkylsulfinyl) is, for example, methylsulfinyl, ethylsulfinyl, propylsulfinyl, isopropylsulfinyl, n-butylsulfinyl, isobutylsulfinyl, sec-butylsulfinyl or tert-butylsulfinyl, preferably methylsulfinyl or ethylsulfinyl.
[0010] C1-C6 alkyl-S(O)2-(alkylsulfonyl) is, for example, methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl or tert-butylsulfonyl, preferably methylsulfonyl or ethylsulfonyl.
[0011] In a preferred embodiment of the present invention, R 1 is selected from the group consisting of methyl, ethyl and n-propyl.
[0012] In another preferred embodiment of the present invention, R 2 is selected from the group consisting of methyl, Cl, —CF 3 and —SO 2 methyl, preferably Cl.
[0013] In another preferred embodiment of the present invention, R 3 is —CF 3 or —CHF 2 .
[0014] In another preferred embodiment of the present invention, the compound of formula (I) (wherein R 4 is selected from the group consisting of C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C1-C3 alkoxy-C1-C3-alkyl-, C3-C6-cycloalkyl-C1-C3 alkyl-, phenyl, and heteroaryl, wherein the phenyl or heteroaryl group may, where chemically appropriate, be optionally substituted with one to four, more preferably one to two, substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkyl, C1-C3 haloalkoxy, and cyano.
[0015] R 4 is heteroaryl, suitable heteroaryls are, for example, Het-1, Het-2, Het-3, Het-4, Het-5, Het-6, Het-7, Het-8 and Het-9 [ka] is selected from the group consisting of:
[0016] These heteroaryl groups may be optionally substituted, where chemically appropriate, with 1 to 4 substituents independently selected from the group consisting of halogen, C1-C3-alkyl, C1-C3-alkoxy, C1-C3 haloalkyl, C1-C3-haloalkoxy and cyano.
[0017] In a further preferred embodiment of the present invention, the compound of formula (I) (wherein R 4 is selected from the group consisting of methyl, ethyl, i-propyl, n-propyl, trifluoromethyl-, methoxyethyl-, cPr, cPr-CH2-, phenyl, Het-1, Het-2, Het-3, Het-4 and Het-5, wherein phenyl, Het-1, Het-2, Het-3, Het-4 and Het-5 may, where chemically appropriate, be optionally substituted with one or two substituents independently selected from the group consisting of halogen, C1-C3-alkyl, C1-C3-alkoxy, C1-C3 haloalkyl, C1-C3-haloalkoxy and cyano.
[0018] In a particularly preferred embodiment, R 4 is selected from the group consisting of C1-C6 alkyl-, C3-C6 cycloalkyl- and C3-C6 cycloalkyl-C1-C3 alkyl-. 4 is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, c-propyl, i-butyl and c-PrCH2-, even more preferably methyl or ethyl.
[0019] In another preferred embodiment of the present invention, R 5 is methyl or hydrogen, preferably hydrogen.
[0020] Compounds of formula (I) (and certain intermediate compounds used to synthesize compounds of formula (I)) may contain asymmetric centers and may exist as single enantiomers, as pairs of enantiomers in any ratio, or, if two or more asymmetric centers are present, may include diastereoisomers in all possible ratios. Typically, one of the enantiomers has greater biological activity than the other possible ones.
[0021] The present invention also includes all possible geometric and tautomeric forms of the compounds of formula (I).
[0022] The present invention also includes agriculturally acceptable salts that the compounds of formula (I) can form with amines (e.g., ammonia, dimethylamine, and triethylamine), alkali metal and alkaline earth metal bases, or quaternary ammonium bases. Among the alkali metal and alkaline earth metal hydroxides, oxides, alkoxides, and hydrogencarbonates and carbonates that can be used as salt formers, the hydroxides, alkoxides, oxides, and carbonates of lithium, sodium, potassium, magnesium, and calcium are important, especially the hydroxides, alkoxides, oxides, and carbonates of sodium, magnesium, and calcium. The corresponding trimethylsulfonium salts can also be used.
[0023] Although the compounds of formula (I) according to the present invention can be used as herbicides themselves, they are generally formulated into herbicidal compositions using formulation auxiliaries such as carriers, solvents, and surfactants (SFAs).Therefore, the present invention further provides a herbicidal composition comprising a herbicidal compound according to the present invention and agriculturally acceptable formulation auxiliaries.This composition can be in the form of a concentrate that is diluted before use, but a ready-to-use composition can also be prepared.Final dilution is usually carried out with water, but can also be carried out with, for example, liquid fertilizer, micronutrients, biological organisms, oil, or solvent instead of or in addition to water.
[0024] The herbicidal compositions generally comprise 0.1 to 99% by weight, in particular 0.1 to 95% by weight, of a compound of formula I and 1 to 99.9% by weight of formulation auxiliaries, preferably including 0 to 25% by weight of a surface-active substance.
[0025] The compositions can be selected from a number of formulations, many of which are known from the Manual on Development and Use of FAO Specifications for Plant Protection Products, 5th Edition, 1999. These include dusts (DP), water-soluble concentrates (SP), water-soluble granules (SG), wettable granules (WG), wettable powders (WP), granules (GR) (sustained or immediate release), soluble concentrates (SL), oil-miscible liquids (OL), ultra-low volume liquids (UL), emulsifiable concentrates (EC), dispersible concentrates (DC), emulsifiable concentrates (both oil-in-water (EW) and water-in-oil (EO)), microemulsions (ME), suspension concentrates (SC), aerosols, capsule suspensions (CS), and seed treatment formulations. In each case, the formulation selected will depend on the specific purpose envisaged and the physical, chemical, and biological properties of the compound of formula (I).
[0026] Dusts (DP) may be prepared by mixing a compound of formula (I) with one or more solid diluents (e.g., natural clay, kaolin, pyrophyllite, bentonite, alumina, montmorillonite, kieselguhr, chalk, diatomaceous earth, calcium phosphate, calcium and magnesium carbonate, sulfur, lime, flour, talc and other organic and inorganic solid carriers) and mechanically grinding the mixture to a fine powder.
[0027] To improve dispersibility / solubility in water, water-soluble granules (SP) can be prepared by mixing the compound of formula (I) with one or more water-soluble inorganic salts (such as sodium bicarbonate, sodium carbonate, or magnesium sulfate) or one or more water-soluble organic solids (such as polysaccharides), and optionally one or more wetting agents, one or more dispersing agents, or a mixture of the above substances. This mixture is then ground into a fine powder. Similar compositions can also be granulated to form water-soluble granules (SG).
[0028] Wettable powders (WP) can be prepared by mixing a compound of formula (I) with one or more solid diluents or carriers, one or more wetting agents, and preferably one or more dispersing agents and optionally one or more suspending agents to facilitate dispersion in a liquid. This mixture is then ground to a fine powder. Similar compositions can also be granulated to form wettable granules (WG).
[0029] Granules (GR) can be formed by either granulating a mixture of a compound of formula (I) with one or more powdered solid diluents or carriers, or by absorbing a compound of formula (I) (or a solution thereof in a suitable material) into a porous granular material (such as pumice, attapulgite clay, fuller's earth, kieselguhr, diatomaceous earth, or ground corncob), or by granulating from preformed blank granules by adsorbing a compound of formula (I) (or a solution thereof in a suitable material) onto a hard core material (such as sand, silicates, inorganic carbonates, sulfates, or phosphates) and optionally drying. Substances commonly used to aid absorption or adsorption include solvents (such as aliphatic and aromatic petroleum-based solvents, alcohols, ethers, ketones, and esters) and binders (such as polyvinyl acetate, polyvinyl alcohol, dextrin, sugars, and vegetable oils). Granules may also contain one or more other additives (e.g., emulsifiers, wetting agents, or dispersing agents).
[0030] Dispersible concentrates (DC) can be prepared by dissolving a compound of formula (I) in water or an organic solvent such as a ketone, alcohol, or glycol ether. These solutions can contain surfactants (e.g., to improve water dilutability or prevent crystallization in the spray tank).
[0031] Emulsifiable concentrates (EC) or oil-in-water emulsions (EW) can be prepared by dissolving a compound of formula (I) in an organic solvent (optionally containing one or more wetting agents, one or more emulsifiers, or mixtures of the foregoing). Suitable organic solvents for use in ECs include aromatic hydrocarbons (such as alkylbenzenes or alkylnaphthalenes exemplified by SOLVESSO 100, SOLVESSO 150, and SOLVESSO 200; SOLVESSO is a registered trademark), ketones (such as cyclohexanone or methylcyclohexanone), and alcohols (such as benzyl alcohol, furfuryl alcohol, or butanol), N-alkylpyrrolidones (such as N-methylpyrrolidone or N-octylpyrrolidone), dimethylamides of fatty acids (C8-C9), and the like. 10 EC products can emulsify spontaneously when added to water to produce emulsions that are stable enough to be spray-applied with appropriate equipment.
[0032] The preparation of EW involves obtaining a compound of formula (I) as a liquid (if it is not liquid at room temperature, it can be melted at a suitable temperature, typically below 70°C) or in solution (by dissolving it in a suitable solvent), and then emulsifying the resulting liquid or solution in water containing one or more SFAs under high shear to produce an emulsion. Suitable solvents for use in EW include vegetable oils, chlorinated hydrocarbons (such as chlorobenzene), aromatic solvents (such as alkylbenzenes or alkylnaphthalenes), and other suitable organic solvents with poor water solubility.
[0033] Microemulsions (MEs) can be prepared by mixing water with a blend of one or more SFAs and one or more solvents to spontaneously form a thermodynamically stable, isotropic liquid formulation. The compound of formula (I) is initially present in either water or the solvent / SFA blend. Suitable solvents for use in MEs include those described above for use in ECs or EWs. MEs can be either oil-in-water or water-in-oil systems (which system is present can be determined by conductivity measurements) and can be suitable for mixing water-soluble and oil-soluble pesticides in the same formulation. MEs are suitable for dilution in water, either remaining as microemulsions or forming traditional oil-in-water emulsions.
[0034] Suspension concentrates (SCs) can comprise aqueous or non-aqueous suspensions of finely divided, insoluble solid particles of a compound of formula (I). SCs can be prepared by ball milling or bead milling a solid compound of formula (I), optionally with one or more dispersing agents, in a suitable medium to produce a fine particle suspension of the compound. One or more wetting agents can be included in the composition, and a suspending agent can be included to reduce the settling rate of the particles. Alternatively, a compound of formula (I) can be dry milled and added to water containing the materials described above to produce the desired end product.
[0035] Aerosol formulations include a compound of formula (I) and a suitable propellant (e.g., n-butane). The compound of formula (I) may also be dissolved or dispersed in a suitable vehicle (e.g., water or a water-miscible liquid such as n-propanol) to provide a composition for use in a non-pressurized, manually operated spray pump.
[0036] Capsule suspensions (CS) can be prepared in a similar manner to the preparation of EW formulations, except that an additional polymerization step is involved, in which each oil droplet is encapsulated by a polymer shell, resulting in an aqueous dispersion of oil droplets containing the compound of formula (I) and, optionally, a carrier or diluent therefor. The polymer shell can be produced by either an interfacial polycondensation reaction or a coacervation procedure. This composition provides controlled release of the compound of formula (I) and can be used for seed treatment. The compound of formula (I) can also be formulated in a biodegradable polymer matrix to provide delayed, controlled release of the compound.
[0037] The composition may contain one or more additives to improve the biological performance of the composition, for example, by improving wetting, retention, or distribution on the surface; rain resistance on the treated surface; or uptake or mobility of the compound of formula (I). Such additives include surface active agents (SFAs), oil-based spray additives, such as certain mineral oils or natural vegetable oils (such as soybean oil and rapeseed oil), and blends of these with other bioenhancement aids (components that can assist or modulate the action of the compound of formula (I)).
[0038] Wetting agents, dispersing agents and emulsifying agents may be SFAs of the cationic, anionic, amphoteric or non-ionic type.
[0039] Suitable cationic SFAs include quaternary ammonium compounds (for example cetyltrimethylammonium bromide), imidazolines and amine salts.
[0040] Suitable anionic SFAs include alkali metal salts of fatty acids, salts of aliphatic monoesters of sulfuric acid (e.g., sodium lauryl sulfate), salts of sulfonated aromatic compounds (e.g., sodium dodecylbenzenesulfonate, calcium dodecylbenzenesulfonate, butylnaphthalene sulfonate, and a mixture of sodium di-isopropyl- and tri-isopropyl-naphthalenesulfonate), ether sulfates, alcohol ether sulfates (e.g., sodium laureth-3-sulfate), ether carboxylic acids (e.g., sodium laureth-3-carboxylate), phosphate esters (products from the reaction of one or more aliphatic alcohols with phosphoric acid (mainly mono-esters) or phosphorus pentoxide (mainly di-esters), for example, the reaction product of lauryl alcohol with tetraphosphoric acid; furthermore, these products may be ethoxylated), sulfosuccinamates, paraffin or olefin sulfonates, taurates, and lignosulfonates.
[0041] Suitable SFAs of the amphoteric type include betaines, propionates and glycinates.
[0042] Suitable non-ionic SFAs include condensation products of alkylene oxides such as ethylene oxide, propylene oxide, butylene oxide, or mixtures thereof, with fatty alcohols (such as oleyl alcohol or cetyl alcohol) or alkylphenols (such as octylphenol, nonylphenol, or octylcresol); partial esters derived from long-chain fatty acids or hexitol anhydrides; condensation products of the above partial esters with ethylene oxide; block polymers (including ethylene oxide and propylene oxide); alkanolamides; simple esters (e.g., fatty acid polyethylene glycol esters); amine oxides (e.g., lauryl dimethylamine oxide); and lecithin.
[0043] Suitable suspending agents include hydrocolloids (such as polysaccharides, polyvinylpyrrolidone or sodium carboxymethylcellulose) and swelling clays (such as bentonite or attapulgite).
[0044] The compounds of the present invention can also be used in mixtures with one or more additional herbicides and / or plant growth regulators, such as acetochlor, acifluorfen (including acifluorfen sodium), aclonifen, ametryn, aminocarbazone, aminopyralid, aminotriazole, atrazine, beflubutamid-M, benquitrione, bensulfuron (including bensulfuron-methyl), bentazone, bicyclopyrone, vilanaphos, bispyribac-sodium, bixlozone, bromacil, bromoxynil, butachlor, butafenacil, and carfent. Trazone (including carfentrazone-ethyl), cloransulam (including cloransulam-methyl), chlorimuron (including chlorimuron-ethyl), chlorotoluron, chlorsulfuron, cinmethylin, clasifos, clethodim, clodinafop (including clodinafop-propargyl), clomazone, clopyralid, cyclopyranyl, cyclopyrimorate, cyclosulfamuron, cyhalofop (including cyhalofop-butyl), 2,4-D (including its choline salt and 2-ethylhexyl ester), 2,4 -DB, desmedipham, dicamba (including its aluminum, aminopropyl, bis-aminopropylmethyl, choline, dichloroprop, diglycolamine, dimethylamine, dimethylammonium, potassium, and sodium salts), diclosulam, difluhenican, diflufenzopyr, dimethachlor, dimethenamid-P, diquat dibromide, diuron, epirifenacil, ethalfluralin, ethofumesate, fenoxaprop (including fenoxaprop-P-ethyl), fenoxasulfon phenquinotrion, fentrazamide, flazasulfuron, florasulam, florpyrauxifen (including florpyrauxifen-benzyl), fluazifop (including fluazifop-p-butyl), flucarbazone (including flucarbazone-sodium), flufenacet, flumetsulam, flumioxazin, fluometuron, flupyrsulfuron (including flupyrsulfuron-methyl-sodium), fluroxypyr (including fluroxypyr-meptyl), fomesafen, foramsulfuron,Glufosinate (including both L-glufosinate and ammonium salts), glyphosate (including its diammonium, isopropylammonium, and potassium salts), halaxifen (including haloxyfop-methyl), haloxyfop (including haloxyfop-methyl), hexazinone, hydantocidin, imazamox (including R-imazamox), imazapic, imazapyr, imazethapyr, indaziflam, iodosulfuron (including iodosulfuron-methyl-sodium), iofensulfuron (iofensulfuron-methyl-sodium), -sodium), ioxynil, isoproturon, isoxaflutole, lancotrione, MCPA, MCPB, mecoprop-P, mesosulfuron (including mesosulfuron-methyl), mesotrione, metamitron, metazachlor, methiozoline, metolachlor, metosulam, metribuzin, metsulfuron, napropamide, nicosulfuron, norflurazon, oxadiazon, oxasulfuron, oxyfluorfen, paraquat dichloride, pendimethalin, penoxsulam, phenmedipham, picloram, pinoxa Dhen, pretilachlor, primisulfuron-methyl, prometryn, propanil, propaquizafop, propyrisulfuron, propyzamide, prosulfocarb, prosulfuron, pyraclonil, pyraflufen (including pyraflufen-ethyl), pyrasulfotole, pyridate, pyriftalid, pyrimisulfan, pyroxasulfone, pyroxsulam, quinclorac, quinmerac, quizalofop (including quizalofop-p-ethyl and quizalofop-p-tefuryl), rimsulfuron, saflufenacil, sethoxydim, simazine, S -Metallochlor, sulfentrazone, sulfosulfuron, tebuthiuron, tefuryltrione, tembotrione, terbuthylazine, terbutryn, tetflupyrrolimet, thiencarbazone, thifensulfuron, thiafenacil, tolpyralate, topramezone, tralkoxydim, triafamone, triallate, triasulfuron, tribenuron (including tribenuron-methyl), triclopyr, trifloxysulfuron (including trifloxysulfuron-sodium), trifludimoxazine, trifluralin, triflusulfuron,3-(2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydropyrimidin-1(2H)-yl)phenyl)-5-methyl-4,5-dihydroisoxazole-5-carboxylic acid ethyl ester, 4-hydroxy-1-methoxy-5-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one, 4-hydroxy-1,5-dimethyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one, 5-ethoxy-4-hydroxy-1-methoxy-5-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one 4-Hydroxy-1-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one, 4-Hydroxy-1,5-dimethyl-3-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]imidazolidin-2-one, (4R)1-(5-tert-butylisoxazol-3-yl)-4-ethoxy-5-hydroxy-3-methyl-imidazolidin-2-one, 3-[2-(3,4-dimethoxyphenyl)-6- Methyl-3-oxo-pyridazine-4-carbonyl]bicyclo[3.2.1]octane-2,4-dione, 2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-5-methyl-cyclohexane-1,3-dione, 2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]cyclohexane-1,3-dione, 2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-5,5-dimethyl-cyclohexane cyclohexane-1,3-dione, 6-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-2,2,4,4-tetramethyl-cyclohexane-1,3,5-trione, 2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-5-ethyl-cyclohexane-1,3-dione, 2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-4,4,6,6-tetramethyl-cyclohexane-1,3-dione,2-[6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]-5-methyl-cyclohexane-1,3-dione, 3-[6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]bicyclo[3.2.1]octane-2,4-dione, 2-[6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]-5,5-dimethyl-cyclohexane-1,3-dione, 6-[6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]-2,2,4,4-tetramethyl-cyclohexane-1,3,5-trione, 2-[6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]cyclohexane-1,3-dione, 4-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-2,2,6,6-tetramethyl-tetrahydropyran-3 ,5-dione, 4-[6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]-2,2,6,6-tetramethyl-tetrahydropyran-3,5-dione, 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-carboxylic acid (agrochemically acceptable esters thereof, e.g., methyl 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-carboxamide, sylate, prop-2-ynyl 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-carboxylate and cyanomethyl 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-carboxylate), 3-ethylsulfanyl-N-(1,3,4-oxadiazol-2-yl)-5-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine-8-carboxamide,3-(Isopropylsulfanylmethyl)-N-(5-methyl-1,3,4-oxadiazol-2-yl)-5-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine-8-carboxamide, 3-(Isopropylsulfonylmethyl)-N-(5-methyl-1,3,4-oxadiazol-2-yl)-5-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine-8-carboxamide, 3-(Ethylsulfonylmethyl)-N-(5-methyl-1,3,4-oxadiazol-2-yl)-5-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine Examples of suitable aryl esters include lysine-8-carboxamide, ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]acetate, 6-chloro-4-(2,7-dimethyl-1-naphthyl)-5-hydroxy-2-methyl-pyridazin-3-one, 1-[2-chloro-6-(5-chloropyrimidin-2-yl)oxy-phenyl]-4,4,4-trifluoro-butan-1-one, and 5-[2-chloro-6-(5-chloropyrimidin-2-yl)oxy-phenyl]-3-(difluoromethyl)isoxazole.
[0045] The mixing partners of the compounds of formula I may also be in the form of esters or salts, as mentioned, for example, in The Pesticide Manual, Sixteenth Edition, British Crop Protection Council, 2012.
[0046] The compounds of formula I may also be used in mixtures with other pesticides such as fungicides, nematicides or insecticides, examples of which are given in The Pesticide Manual.
[0047] The mixing ratio of the compound of formula I to the mixing partner is preferably 1:100 to 1000:1.
[0048] Mixtures may advantageously be used in the abovementioned formulations (in which case "active ingredient" relates to the respective mixture of the compound of formula I with the mixing partner).
[0049] The compound or mixture of the present invention can also be used in combination with one or more herbicide safeners. Examples of such safeners include benoxacor, cloquintocet (including cloquintocet-mexyl), cyprosulfamide, dichlormid, fenchlorazole (including fenchlorazole-ethyl), fenclorim, fluxofenim, furilazole, isoxadifen (including isoxadifen-ethyl), mefenpyr (including mefenpyr-diethyl), metcamifen, and oxabetrinil. Particularly preferred is a mixture of the compound of formula I with cyprosulfamide, isoxadifen-ethyl, cloquintocet-mexyl, and / or metcamifen.
[0050] The safeners of the compounds of formula I are described, for example, in The Pesticide Manual, 16 th Edition (BCPC), 2012. A reference to cloquintocet-mexyl also applies to its lithium, sodium, potassium, calcium, magnesium, aluminum, iron, ammonium, quaternary ammonium, sulfonium or phosphonium salts as disclosed in WO 02 / 34048, a reference to fenchlorazole-ethyl also applies to fenchlorazole, etc.
[0051] Preferably, the mixing ratio of compound of formula I to safener is from 100:1 to 1:10, in particular from 20:1 to 1:1.
[0052] Mixtures may be advantageously used in the formulations described above (in which case "active ingredient" refers to the respective mixture of compound of formula I and safener).
[0053] The present invention further provides a method for controlling weeds in a habitat, the method comprising applying to the weed habitat a weed-controlling amount of a composition comprising a compound of formula (I). The present invention also provides a method for selectively controlling weeds in a habitat containing crop plants and weeds, the method comprising applying to the habitat a weed-controlling amount of a composition of the present invention. "Control" means killing, reducing or delaying growth, or preventing or reducing germination. Generally, the plants to be controlled are unwanted plants (weeds). "Habitat" refers to the area where plants are growing or will grow. Some crop plants may be innately resistant to the herbicidal effect of a compound of formula (I). However, in some cases, resistance may need to be artificially introduced into the crop plants, for example, by genetic engineering. Thus, it is possible to confer resistance to HPPD inhibitors to crop plants through genetic engineering. Methods for conferring resistance to HPPD inhibitors to crop plants are known, for example, from WO 0246387. Thus, in a more preferred embodiment, the crop plant is transgenic for a polynucleotide comprising a DNA sequence encoding an HPPD inhibitor-resistant HPPD enzyme from a bacterium, more particularly from Pseudomonas fluorescens or Shewanella colwelliana, or an HPPD inhibitor-resistant HPPD enzyme from a plant, more particularly from a monocotyledonous plant, or even more particularly from barley, maize, wheat, rice, Brachiaria, Cenchrus, Lolium, Festuca, Setaria, Eleusine, Sorghum, or Avena species. A number of HPPD-resistant soybean transgenic "events" are known, including, for example, SYHT04R (WO 2012 / 082542), SYHT0H2 (WO 2012 / 082548), and FG72.Other polynucleotide sequences that can be used to render plants tolerant to the compounds of the invention are disclosed, for example, in WO 2010 / 085705 and WO 2011 / 068567. Crop plants for which the compositions of the invention can be used therefore include crops such as cereals such as barley and wheat, cotton, oilseed rape, sunflower, corn, rice, soybean, sugar beet, sugarcane and turf.
[0054] Crop plants may also include trees such as fruit trees, palm trees, coconut trees or other nut trees. Also included are climbing plants such as grapes, fruit shrubs, fruit plants and vegetables.
[0055] The application rates of the compounds of formula I may vary within wide limits and depend on the nature of the soil, the method of application (pre- or post-emergence; seed dressing; application in the seed furrow; non-arable application, etc.), the crop, the weeds to be controlled, the prevailing climatic conditions and other factors influenced by the method of application, the time of application and the target crop. The compounds of formula I according to the invention are generally applied at a rate of 10 to 2000 g / ha, in particular 50 to 1000 g / ha.
[0056] Application is generally by spraying the composition, typically with a tractor-mounted sprayer for large areas, although other methods such as dusting (for dusts), dripping or dredging can also be used.
[0057] It should be understood that crops also include crops that have been made tolerant to herbicides or classes of herbicides (e.g., ALS-, GS-, EPSPS-, PPO-, ACCase-, and HPPD inhibitors) by conventional breeding methods or genetic engineering. An example of a crop that has been made tolerant to imidazolinones, such as imazamox, by conventional breeding methods is Clearfield® summer rapeseed (canola). Examples of crops that have been made tolerant to herbicides by genetic engineering methods include, for example, glyphosate- and glufosinate-resistant corn varieties commercially available under the trade names RoundupReady® and LibertyLink®.
[0058] Crops should also be understood to include crops that have been made resistant to pests by genetic engineering methods, such as Bt corn (resistant to the European corn borer), Bt cotton (resistant to the Mexican boll weevil), and even Bt potato (resistant to the Colorado potato beetle). An example of Bt corn is the Bt 176 corn hybrid from NK® (Syngenta Seeds). Bt toxins are proteins naturally formed by the soil bacterium Bacillus thuringiensis. Examples of toxins or transgenic plants capable of synthesizing such toxins are described in EP 451878, EP 374753, WO 93 / 07278, WO 95 / 34656, WO 03 / 052073, and EP 427529. Examples of transgenic plants containing one or more genes encoding insecticide resistance and expressing one or more toxins are KnockOut® (corn), Yield Gard® (corn), NuCOTIN33B® (cotton), Bollgard® (cotton), NewLeaf® (potato), NatureGard®, and Protexcta®. Either the plant crop or its seed material can be resistant to herbicides and insect feeding at the same time (a "multiple" transgenic event). For example, seeds can have the ability to express the insecticidal Cry3 protein and be resistant to glyphosate at the same time.
[0059] It should be understood that crops also include crops obtained by traditional breeding methods or by genetic modification and containing so-called output traits (e.g., improved storage stability, higher nutritional value and improved flavor).
[0060] Other useful plants include ornamental plants such as turfgrasses and flowers or shrubs grown commercially for turfgrass or lawns, for example, on golf courses, lawns, parks and roadsides.
[0061] The compositions can be used to control undesirable plants (collectively "weeds"), such as monocotyledonous species of plants, such as Agrostis, Alopecurus, Avena, Brachiaria, Bromus, Cenchrus, Cyperus, Digitaria, Echinochloa, Eleusine, Lolium, Monochoria, Rottboellia, Sagittaria, Scirpus, Setaria, and the like. ), and Sorghum, as well as dicotyledonous species such as Abutilon, Amaranthus, Ambrosia, Chenopodium, Chrysanthemum, Conyza, Galium, Ipomoea, Nasturtium, Sida, Sinapis, Solanum, Stellaria, Veronica, Viola and Xanthium. Weeds may also be considered crops, but may also include plants that grow outside of the crop area ("escapes") or plants that grow from seeds left over from a different previously planted crop ("volunteers"). Such volunteers or escapes may be resistant to certain other herbicides.
[0062] The compounds of the present invention can be prepared according to the following schemes.
[0063] Compounds of formula (I) can be prepared from benzoic acids of formula (II) and amines of formula (III). [ka]
[0064] According to the above scheme, a benzoic acid of formula (II) and an amine of formula (III) are treated with a suitable amide coupling reagent in a suitable solvent. An additive that enhances the reaction rate can be optionally added. An example of a suitable amide coupling reagent is thionyl chloride. An example of a suitable solvent is pyridine. An example of a suitable additive is N-methylimidazole.
[0065] The benzoic acid of formula (II) can be prepared by hydrolyzing the ester of formula (IV), where "Alk" is defined as a C1-C6 alkyl (preferably methyl or ethyl) group. [ka]
[0066] According to the above scheme, the benzoic acid of formula (IV) is treated with a hydroxide base, for example sodium hydroxide, in a suitable solvent, for example a 3:1 mixture of ethanol:water, to give the compound of formula (II).
[0067] Compounds of formula (IV) can be prepared from anilines of formula (V) and sulfonyl chlorides of formula (VI). [ka]
[0068] The aniline of formula (V) is treated with a sulfonyl chloride of formula (VI) in a suitable solvent, for example, tetrahydrofuran. 2 , R 3 and R 5 A base may be required depending on the nature of the base. An example of a suitable base is lithium hexamethyldisilazane.
[0069] Compounds of formula (V) can be prepared from compounds of formula (VII). [ka]
[0070] The condition used in this transformation is R 2 For example, R 2 When is chlorine, the compound of formula (VII) is treated with sulfuryl chloride and a catalytic amount of diisopropylamine.
[0071] Alternatively, a compound of formula (I) can be prepared from a compound of formula (VIII) and a sulfonyl chloride of formula (VI). [ka]
[0072] A compound of formula (VIII) is treated with a compound of formula (VI) in a suitable solvent, for example acetonitrile, to give a compound of formula (I).
[0073] A compound of formula (VIII) can be prepared from a compound of formula (IX) and an amine of formula (III). [ka]
[0074] The compound of formula (IX) and the compound of formula (III) are treated with a base, for example 2-tert-tutylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine, in a suitable solvent, for example acetonitrile.
[0075] Compounds of formula (IX) can be prepared from benzoic acid of formula (X) and pentafluorophenol. [ka]
[0076] A compound of formula (X) is treated with pentafluorophenol and an ester coupling reagent, such as 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, in a suitable solvent, such as dichloromethane.
[0077] Compounds of formula (X) can be prepared from compounds of formula (V), where "Alk" is defined as a C1-C6 alkyl group. [ka]
[0078] Compounds of formula (V) are treated with a hydroxide base, for example sodium hydroxide, in a suitable solvent, for example a 3:1 mixture of ethanol:water, to give compounds of formula (X).
[0079] The present invention further provides a compound of formula (II) [ka] (In the formula, R 2 , R 3 and R 5 is as defined for compounds of formula (I), and R 4 is C1-C6 alkyl).
[0080] In a preferred embodiment, the compound of formula (II) (wherein R 2 is methyl or chloro, and R 3 is CF3 or CHF2, and R 4 is selected from the group consisting of methyl, ethyl, i-propyl, n-propyl, i-butyl, c-propyl, and c-propyl-(CH)- (more preferably methyl or ethyl), and R 5 is selected from the group consisting of hydrogen, methyl, or ethyl.
[0081] The present invention further provides a compound of formula (IV) [ka] (In the formula, R 2 , R 3 , R 4 and R 5 is as defined in the compound of formula (I), and "Alk" is C1-C6 alkyl (more preferably methyl or ethyl). In a preferred embodiment, a compound of formula (II) (wherein R 2 is methyl or chloro, and R 3 is CF3 or CHF2, and R 4 is selected from the group consisting of methyl, ethyl, i-propyl, n-propyl, i-butyl, c-propyl, and c-propyl-(CH)- (more preferably methyl or ethyl), and R 5 is selected from the group consisting of hydrogen, methyl, or ethyl.
[0082] The following non-limiting examples provide specific methods for synthesizing representative compounds of the invention referenced in the tables herein. [Example]
[0083] Example P1. Preparation of compound 1.002. Step 1: Preparation of methyl 3-amino-2-chloro-4-(trifluoromethoxy)benzoate To a round-bottom flask containing methyl 3-amino-4-(trifluoromethoxy)benzoate (3.00 g, 12.8 mmol) was added toluene (45 mL) and diisopropylamine (0.13 g, 1.3 mmol). The reaction mixture was heated to 70 °C. Sulfuryl chloride (1.55 g, 11.5 mmol) was added slowly to the reaction mixture over 10 minutes, causing the reaction mixture to immediately turn yellow and release gas. After the addition was complete, the reaction mixture was stirred for an additional 40 minutes and then cooled. Water (30 mL) was added and the toluene was removed under reduced pressure. The reaction mixture was poured into a separatory funnel and extracted with ethyl acetate (2 × 60 mL). The combined organic layers were washed with brine (30 mL), dried over MgSO4, and concentrated. The residue was purified by reverse-phase column chromatography (gradient of 40–80% MeCN in HO with 0.1% formic acid) to give methyl 3-amino-2-chloro-4-(trifluoromethoxy)benzoate (1.88 g, 6.97 mmol, 55%) as a yellow liquid. 1H NMR (400 MHz, d4-methanol) δ ppm 7.19 (dq, J = 8.56, 1.55 Hz, 1H), 7.07 (d, J = 8.80 Hz, 1H), 3.87–3.91 (s, 3H).
[0084] Step 2: Preparation of 3-amino-2-chloro-4-(trifluoromethoxy)benzoic acid To a stirred solution of methyl 3-amino-2-chloro-4-(trifluoromethoxy)benzoate (10.0 g, 37.1 mmol) in tetrahydrofuran (120 mL) and water (30 mL) at room temperature was added lithium hydroxide monohydrate (4.67 g, 111 mmol). The mixture was stirred at room temperature for 22 hours. The mixture was then cooled to 0°C (ice-water bath). The reaction was quenched by the slow addition of 2 M aqueous HCl (100 mL). The cooling bath was removed and the mixture was allowed to warm to room temperature. EtOAc (100 mL) and brine (50 mL) were added and the phases were separated. The aqueous phase was extracted with EtOAc (100 mL). The combined organic phases were dried (MgSO), filtered, and concentrated in vacuo to give 3-amino-2-chloro-4-(trifluoromethoxy)benzoic acid (9.25 g, 34.4 mmol, 93%) as a beige solid, which was used in the next step without further purification. H NMR (400 MHz, CDOD): δ = 7.20-7.15 (m, 1H), 7.13-7.08 (m, 1H).
[0085] Step 3: Preparation of (2,3,4,5,6-pentafluorophenyl) 3-amino-2-chloro-4-(trifluoromethoxy)benzoate To a stirred suspension of 3-amino-2-chloro-4-(trifluoromethoxy)benzoic acid (9.24 g, 36.2 mmol) and 2,3,4,5,6-pentafluorophenol (7.32 g, 39.8 mmol) in dichloromethane (139 mL) at room temperature was added 3-(ethyliminomethyleneamino)-N,N-dimethyl-propan-1-amine hydrochloride (8.32 g, 43.4 mmol). The mixture was stirred at room temperature for 1 hour. The reaction was then quenched by the addition of saturated aqueous NaHCO3 (100 mL). The mixture was stirred at room temperature for an additional 5 minutes. Dichloromethane (40 mL) was added and the phases were separated. The aqueous phase was extracted with dichloromethane (50 mL). The combined organic phases were passed through a phase separation cartridge. The filtrate was adsorbed onto silica, and the crude product was purified by flash column chromatography (98:2 to 93:7 cyclohexane / EtOAc gradient). Product-containing fractions were combined and concentrated in vacuo to give (2,3,4,5,6-pentafluorophenyl)3-amino-2-chloro-4-(trifluoromethoxy)benzoate (12.54 g, 29.74 mmol, 82%) as a pale yellow crystalline solid. 1H NMR (400 MHz, CDCl3) δ = 7.53 (d, 1H), 7.26-7.22 (m, 1H), 4.62 (br s, 2H).
[0086] Step 4: Preparation of 3-amino-2-chloro-N-(1-ethyltetrazol-5-yl)-4-(trifluoromethoxy)benzamide To a stirred solution of (2,3,4,5,6-pentafluorophenyl) 3-amino-2-chloro-4-(trifluoromethoxy)benzoate (6.00 g, 14.2 mmol) in acetonitrile (120 mL) at room temperature was added 1-ethyltetrazol-5-amine (3.54 g, 31.3 mmol), followed by 2-tert-butylimino-N,N-diethyl-1,3-dimethyl-1,3,2λ 5To the resulting solution was added 2M HCl (100 mL, 31.3 mmol). The mixture was stirred at room temperature for 30 minutes. The reaction was then quenched by the addition of 2M aqueous HCl (100 mL). The mixture was stirred at room temperature for an additional 5 minutes and then diluted with EtOAc (100 mL). The phases were separated. The aqueous phase was extracted with EtOAc (100 mL). The combined organic phases were washed with brine (100 mL), dried (MgSO), filtered, and adsorbed onto C18-silica. The crude product was partially purified by reverse-phase chromatography (40:60 to 60:40 acetonitrile + 0.1% formic acid / water + 0.1% formic acid gradient). The product-containing fractions were combined, partially concentrated in vacuo to remove acetonitrile, and lyophilized to give the partially purified material. The partially purified material was adsorbed onto C18-silica and further purified by reverse-phase chromatography (35:65 to 55:45 acetonitrile + 0.1% formic acid / water + 0.1% formic acid gradient). The purified fractions were combined and partially concentrated in vacuo to remove MeCN. The mixture was then diluted with brine (50 mL) and extracted with EtOAc (2 × 150 mL). The combined organic phases were dried (MgSO4), filtered, and concentrated in vacuo to give 3-amino-2-chloro-N-(1-ethyltetrazol-5-yl)-4-(trifluoromethoxy)benzamide (4.26 g, 11.5 mmol, 81%) as a white foam. 1H NMR (400 MHz, CD3OD): δ = 7.27 (dq, 1H), 6.94 (d, 1H), 4.42 (q, 2H), 1.58 (t, 3H).
[0087] Step 5: Preparation of 2-chloro-3-(ethylsulfonylamino)-N-(1-ethyltetrazol-5-yl)-4-(trifluoromethoxy)benzamide To a stirred solution of 3-amino-2-chloro-N-(1-ethyltetrazol-5-yl)-4-(trifluoromethoxy)benzamide (250 mg, 0.677 mmol) in acetonitrile (2.50 mL) was added ethanesulfonyl chloride (1.28 mL, 13.5 mmol) at room temperature. The stirred mixture was heated to gentle reflux (heating plate temperature: 90 °C) for 72 h. The mixture was cooled to room temperature. Water (1 mL) was added. The mixture was stirred at room temperature for an additional 1 h and then diluted with EtOAc (20 mL), water (10 mL), and brine (20 mL). The phases were separated. The aqueous phase was extracted with EtOAc (20 mL). The combined organic phases were dried (MgSO4), filtered, and concentrated in vacuo. The crude product was partially purified by reverse-phase flash chromatography (30:70 to 50:50 acetonitrile + 0.1% formic acid / water + 0.1% formic acid gradient). Product-containing fractions were combined and partially concentrated in vacuo to remove acetonitrile, then lyophilized to give partially purified material. The partially purified material was then further purified by flash column chromatography (DCM / MeOH gradient 99:1 to 92:8). The purified fractions were combined and concentrated in vacuo to give 2-chloro-3-(ethylsulfonylamino)-N-(1-ethyltetrazol-5-yl)-4-(trifluoromethoxy)benzamide (116 mg, 0.249 mmol, 37%) as an off-white solid. 1H NMR (400MHz, MeCN-d3): δ=7.69(d,1H),7.54-7.48(m,1H),4.33(q,2H),3.31(q,2H),1.53(t,3H),1.44(t,3H).
[0088] Example P2. Preparation of compound 1.003. Methyl 3-amino-2-chloro-4-(trifluoromethoxy)benzoate was prepared analogously to step 1 of the preparation of 1.002. Step 1: Preparation of methyl 2-chloro-3-(ethylsulfonylamino)-4-(trifluoromethoxy)benzoate To a stirred solution of methyl 3-amino-2-chloro-4-(trifluoromethoxy)benzoate (1.00 g, 3.52 mmol) in tetrahydrofuran (10.0 mL, anhydrous) under a nitrogen atmosphere at −78° C., lithium bis(trimethylsilyl)amide (1 M in THF, 8.81 mL, 8.81 mmol) was added dropwise over 15 minutes. The mixture was stirred at −78° C. for 45 minutes, and then ethanesulfonyl chloride (0.434 mL, 4.58 mmol) was added dropwise over 2 minutes. The mixture was stirred at −78° C. for an additional 2 hours. The reaction was then quenched by the addition of saturated aqueous NH4Cl (5 mL). The mixture was allowed to warm to room temperature. EtOAc (40 mL) and 2 M aqueous HCl (40 mL) were added, and the phases were separated. The aqueous phase was extracted with EtOAc (40 mL). The combined organic phases were washed with brine (60 mL), dried (MgSO), filtered, and concentrated in vacuo. The crude product was purified by flash column chromatography on silica (90:10 to 60:40 cyclohexane / EtOAc gradient). The product-containing fractions were combined and concentrated in vacuo to give methyl 2-chloro-3-(ethylsulfonylamino)-4-(trifluoromethoxy)benzoate (0.686 g, 1.80 mmol, 51%) as an off-white solid. 1 H NMR (400 MHz, chloroform-d): δ = 7.83 (d, 1H), 7.33 (dq, 1H), 6.19 (s, 1H), 3.40 (q, 2H), 1.55 (t, 3H).
[0089] Step 2: Preparation of 2-chloro-3-(ethylsulfonylamino)-4-(trifluoromethoxy)benzoic acid To a stirred solution of methyl 2-chloro-3-(ethylsulfonylamino)-4-(trifluoromethoxy)benzoate (1.89 g, 4.96 mmol) in tetrahydrofuran (15 mL) and water (3.8 mL) at room temperature was added lithium hydroxide monohydrate (0.625 g, 14.9 mmol). The mixture was stirred at room temperature for 5 hours. The mixture was then cooled to 0°C (ice-water bath) and quenched by the addition of 2 M aqueous HCl (20 mL). The mixture was stirred at 0°C for 5 minutes, then the cooling bath was removed and the mixture was allowed to warm to room temperature. EtOAc (50 mL) and brine (30 mL) were added, and the phases were separated. The aqueous phase was extracted with EtOAc (50 mL). The combined organic phases were dried (MgSO), filtered, and concentrated in vacuo to afford 2-chloro-3-(ethylsulfonylamino)-4-(trifluoromethoxy)benzoic acid (1.79 g, 4.89 mmol, 99%) as a pale yellow oil, which was used in the next step without further purification. 1 H NMR (400 MHz, acetonitrile-d3): δ = 7.85 (d, 1H), 7.43 (dq, 1H), 7.22 (br s, 1H), 3.29 (q, 2H), 1.42 (t, 3H).
[0090] Step 3: Preparation of 2-chloro-3-(ethylsulfonylamino)-N-(1-methyltetrazol-5-yl)-4-(trifluoromethoxy)benzamide To a solution of 2-chloro-3-(ethylsulfonylamino)-4-(trifluoromethoxy)benzoic acid (0.578 g, 1.58 mmol) and 1-methyltetrazol-5-amine (0.188 g, 1.90 mmol) was added pyridine (5.8 mL) followed by 1-methylimidazole (0.127 mL, 1.58 mmol) at room temperature under a nitrogen atmosphere. The stirred mixture was cooled to 0 °C (ice-water bath) and thionyl chloride (0.232 mL, 3.16 mmol) was added dropwise. The stirred mixture was then warmed to room temperature and stirred for 17 hours. The mixture was then concentrated under reduced pressure. The residue was dissolved in a mixture of EtOAc (40 mL) and 2 M aqueous HCl (40 mL). The phases were separated and the aqueous phase was extracted with EtOAc (40 mL). The combined organic phases were washed with brine (50 mL), dried (MgSO), filtered, and concentrated in vacuo to give the crude product as a pale yellow foam. The crude product was suspended in 2-propanol (6 mL) and the mixture was heated to 100 °C. All material dissolved to give a pale yellow solution. The mixture was cooled to room temperature. The precipitated solid was filtered off and dried under reduced pressure. The collected solid was recombined with the filtrate and adsorbed onto silica. This material was then purified by flash column chromatography on silica (CHCl / MeOH gradient 99:1 to 90:10). The product-containing fractions were combined and concentrated in vacuo to give a colorless gum. MTBE was added, and the mixture was again concentrated in vacuo to give a sticky white solid. This was dissolved in DCM / MeOH, concentrated in vacuo, and then further dried under high vacuum to give 2-chloro-3-(ethylsulfonylamino)-N-(1-methyltetrazol-5-yl)-4-(trifluoromethoxy)benzamide (0.085 g, 0.19 mmol, 12%) as an off-white solid. 1 H NMR (400 MHz, acetonitrile-d3): δ = 7.70 (d, 1H), 7.56–7.48 (m, 1H), 3.98 (s, 3H), 3.31 (q, 2H), 1.44 (t, 3H).
[0091] Example P3. Preparation of compound 1.011. Step 1: Preparation of 3-amino-2-chloro-4-(difluoromethoxy)benzoic acid To a stirred solution of methyl 3-amino-2-chloro-4-(difluoromethoxy)benzoate (15.3 g, 60.7 mmol) in tetrahydrofuran (122 mL) and water (31 mL) at room temperature was added lithium hydroxide monohydrate (7.65 g, 182 mmol). The mixture was stirred at room temperature for 26 hours. The mixture was then cooled to 0°C (ice-water bath). The reaction was then quenched by the slow addition of 2 M aqueous HCl (150 mL). The cooling bath was removed and the mixture was allowed to warm to room temperature. EtOAc (150 mL) and brine (100 mL) were added and the phases were separated. The aqueous phase was extracted with EtOAc (100 mL). The combined organic phases were dried (MgSO), filtered, and concentrated in vacuo to afford 3-amino-2-chloro-4-(difluoromethoxy)benzoic acid (14.6 g, 55.1 mmol, 91%) as a beige solid, which was used in the next step without further purification. 1 H NMR (400 MHz, methanol-d₄) δ = 7.15 (d, 1H), 7.08–7.03 (m, 1H), 6.87 (t, 1H).
[0092] Step 2: Preparation of (2,3,4,5,6-pentafluorophenyl) 3-amino-2-chloro-4-(difluoromethoxy)benzoate Acetonitrile (102 mL) was added to 3-amino-2-chloro-4-(difluoromethoxy)benzoic acid (14.5 g, 55.1 mmol), and the mixture was stirred at room temperature for 5 minutes. A solution of 2,3,4,5,6-pentafluorophenol (11.2 g, 60.6 mmol) in acetonitrile (44 mL) was added, followed by 3-(ethyliminomethyleneamino)-N,N-dimethyl-propan-1-amine hydrochloride (12.7 g, 66.1 mmol). The mixture was stirred at room temperature for 2 hours. The reaction was then quenched by the addition of 2 M aqueous HCl (150 mL). The mixture was stirred at room temperature for an additional 5 minutes, then transferred to a separatory funnel and rinsed with EtOAc (3 × 20 mL). EtOAc (200 mL) and brine (150 mL) were added, and the phases were separated. The organic phase was washed with saturated aqueous NaHCO (200 mL), then dried (MgSO), and filtered. The filtrate was adsorbed onto silica (100 g) and purified by flash column chromatography on silica (96:4 to 80:20 cyclohexane / EtOAc gradient). Product-containing fractions were combined and concentrated in vacuo to give (2,3,4,5,6-pentafluorophenyl)3-amino-2-chloro-4-(difluoromethoxy)benzoate (19.9 g, 46.9 mmol, 85%) as a pale yellow oil. 1 H NMR (400 MHz, chloroform-d): δ = 7.55 (d, 1H), 7.11 (d, 1H), 6.62 (t, 1H), 4.59 (br s, 2H).
[0093] Step 3: Preparation of (2,3,4,5,6-pentafluorophenyl) 2-chloro-4-(difluoromethoxy)-3-(propylsulfonylamino)benzoate To a solution of (2,3,4,5,6-pentafluorophenyl)3-amino-2-chloro-4-(difluoromethoxy)benzoate (0.8 g, 2 mmol) in tetrahydrofuran (8 mL) was added lithium bis(trimethylsilyl)amide (1 M in THF, 5 mL, 5 mmol) dropwise at −78° C. The mixture was stirred at −78° C. for 45 minutes. Then, propane-1-sulfonyl chloride (0.3 mL, 3 mmol) was added dropwise. The mixture was stirred at −78° C. for 2 hours. The reaction was then quenched with saturated aqueous NH4Cl. 2N HCl was added, and the mixture was extracted three times with EtOAc. The combined organic phases were washed with brine, dried over Na2SO4, and concentrated in vacuo. The crude product was adsorbed onto silica and purified by flash column chromatography on silica (cyclohexane / EtOAc 70:30) to give (2,3,4,5,6-pentafluorophenyl) 2-chloro-4-(difluoromethoxy)-3-(propylsulfonylamino)benzoate (0.47 g, 0.92 mmol, 50%) as a white solid. 1 H NMR (400MHz, DMSO-d6): δ ppm 9.61(s,1H),8.22(d,1H),7.32-7.73(m,2H),3.17-3.26(m,2H),1.86(br d,2H),1.01(t,3H).
[0094] Step 4: Preparation of 2-chloro-4-(difluoromethoxy)-N-(1-methyltetrazol-5-yl)-3-(propylsulfonylamino)benzamide To a stirred solution of 1-methyltetrazol-5-amine (0.14 g, 1.4 mmol) in DMF (3 mL) was added 2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine (1.4 mL, 4.6 mmol) at room temperature. The mixture was stirred at room temperature for 30 minutes. To this was added a solution of (2,3,4,5,6-pentafluorophenyl)2-chloro-4-(difluoromethoxy)-3-(propylsulfonylamino)benzoate (0.47 g, 0.92 mmol) in DMF (3 mL), and the mixture was stirred at room temperature overnight. The reaction was quenched with 1N HCl and extracted three times with ethyl acetate. The combined organic phase was washed three times with ice water, then with brine, dried over Na2SO4, and concentrated in vacuo. The resulting solid was washed three times with MTBE and dried under reduced pressure to give 2-chloro-4-(difluoromethoxy)-N-(1-methyltetrazol-5-yl)-3-(propylsulfonylamino)benzamide (0.16 g, 0.38 mmol, 41%) as an off-white solid. 1 H NMR(400MHz,DMSO-d6):δ ppm 11.87(s,1H),9.53(s,1H)7.77(d,1H)7.41(t,1H)7.39(d,1H)4.00(s,3H)3.13-3.28(m,2H)1.82-1.92(m,2H)1.02(t,3H).
[0095] [Table 1-1] [Table 1-2] [Table 1-3] [Table 1-4] [Table 1-5] [Table 1-6] Table 1-7 Table 1-8 Table 1-9 Table 1-10 Table 1-11 Table 1-12 Table 1-13 Table 1-14 Table 1-15 Table 1-16 Table 1-17 Table 1-18 Table 1-19
[0096] Table 2
[0097] examples of biology Seeds of various test species (Lolium perenne (LOLPE), Amaranthus retoflexus (AMARE), Amaranthus palmeri (AMAPA), Abutilon theophrasti (ABUTH), Setaria faberi (SETFA), Echinochloa crus-galli (ECHCG), and Ipomoea hederacea (IPOHE)) are sown in standard soil in pots. After 1 day of cultivation (pre-emergence) or 8 days of cultivation (post-emergence) under controlled conditions in a greenhouse (24 / 16°C, day / night; 14 hours of light; 65% humidity), the plants are sprayed with an aqueous spray solution obtained from a formulation of the technical active ingredient in an acetone / water (50:50) solution containing 0.5% Tween 20 (polyoxyethylene sorbitan monolaurate, CAS RN9005-64-5). Unless otherwise specified, the compounds are applied at 130 g / h. The test plants are then cultivated in a greenhouse under controlled greenhouse conditions (24 / 16°C, day / night; 14 hours of light; 65% humidity), watering twice a day. After 13 days, the test is evaluated for the percentage of damage caused to the plants before and after emergence. Biological activity is shown in the table below on a 5-point scale (5=80-100%; 4=60-79%; 3=40-59%; 2=20-39%; 1=0-19%).
[0098] [Table 3]
[0099] Table B2 - Comparison Tests Seeds of the test species were sown in standard soil in pots. After one day of cultivation in a greenhouse under controlled conditions (24 / 16°C, day / night; 14 hours of light; 65% humidity), the plants were sprayed with an aqueous spray solution obtained from a formulation of the technical active ingredients in acetone (0.6 ml) and a formulation solution (45 ml) containing 10.6% Emulsogen EL (registration number 61791-12-6), 42.2% N-methylpyrrolidone, 42.2% dipropylene glycol monomethyl ether (CAS RN 34590-94-8) and 0.2% X-77 (CAS RN 11097-66-8).
[0100] The test plants were then grown in a greenhouse under controlled conditions (24 / 16°C, day / night; 14 hours of light; 65% humidity) and watered twice daily. After 14 days, the tests were evaluated (100 = total damage to the plants; 0 = no damage to the plants).
[0101] Test species: AMARE (Amaranthus retoflexus); ECHCG (Echinochloa crus-galli); SETFA (Setaria faberi), IPOHE (Ipomoea hederacea).
[0102] [Table 4]
[0103] C1 is compound 4-363 disclosed in WO 2012 / 028579. Thus, an unexpected improvement in weed control was observed by introducing a 3-sulfonamide substituent on the phenyl ring.
Claims
1. Formula (I): 【Chemistry 1】 (In the formula: R 1 is C 1 ~C 4 Alkyl-, C 1 ~C 4 Haloalkyl-, C 1 ~C 4 Alkoxy-C 1 ~C 4 Alkyl- and C 1 ~C 4 Haloalkoxy-C 1 ~C 4 selected from the group consisting of alkyl-; R 2 is a halogen, C 1 ~C 6 Alkyl-, C 1 ~C 3 Alkoxy-, C 1 ~C 6 Haloalkyl- and -S(O) p C 1 ~C 6 selected from the group consisting of alkyl; R 3 is C 1 ~C 6 haloalkyl; R 4 is C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 3 ~C 6 Cycloalkyl, C 1 ~C 3 Alkoxy-C 1 ~C 3 -Alkyl-, C 3 ~C 6 -cycloalkyl-C 1 ~C 3 alkyl-, phenyl and heteroaryl, wherein the phenyl or heteroaryl group may, where chemically feasible, be selected from the group consisting of halogen, C 1 ~C 3 -Alkyl, C 1 ~C 3 Alkoxy, C 1 ~C 3 Haloalkyl, C 1 ~C 3 - optionally substituted with 1 to 4 substituents independently selected from the group consisting of haloalkoxy and cyano; R 5 is hydrogen or C 1 ~C 3 is alkyl; p is 0, 1 or 2. or an agriculturally acceptable salt thereof.
2. R 1 The compound of claim 1, wherein is selected from the group consisting of methyl, ethyl, and n-propyl.
3. R 2 is methyl, Cl, -CF 3 and -SO 2 3. The compound of claim 1 or 2, wherein the compound is selected from the group consisting of methyl.
4. R 2 The compound of claim 3, wherein is Cl.
5. R 3 is -CF 3 or -CHF 2 The compound according to any one of claims 1 to 4,
6. R 4 is C 1 ~C 6 Alkyl, C 1 ~C 6 Haloalkyl, C 3 ~C 6 Cycloalkyl, C 1 ~C 3 Alkoxy-C 1 ~C 3 -Alkyl-, C 3 ~C 6 -cycloalkyl-C 1 ~C 3 alkyl-, phenyl and heteroaryl, wherein the phenyl or heteroaryl group may, where chemically feasible, be selected from the group consisting of halogen, C 1 ~C 3 -Alkyl, C 1 ~C 3 Alkoxy, C 1 ~C 3 Haloalkyl, C 1 ~C 3 The compound of any one of claims 1 to 5, optionally substituted with 1 to 4 substituents independently selected from the group consisting of haloalkoxy and cyano.
7. R 4 is C 1 ~C 6 The compound of claim 6, wherein the compound is alkyl.
8. R 4 is methyl or ethyl.
9. R 5 The compound according to any one of claims 1 to 8, wherein is hydrogen.
10. A herbicidal composition comprising the compound according to any one of claims 1 to 9 and an agriculturally acceptable formulation adjuvant.
11. 11. The herbicidal composition of claim 10 further comprising at least one additional pesticide.
12. 12. The herbicidal composition of claim 11, wherein the additional pesticide is a herbicide or a herbicide safener.
13. 13. A method of controlling weeds in a propagation site, the method comprising the step of applying to said propagation site a weed controlling amount of a composition according to any one of claims 10 to 12.
14. 10. Use of a compound of formula (I) according to claim 1 as a herbicide.
15. Formula (II) 【Chemistry 2】 (In the formula, R 2 , R 3 and R 5 is as defined above in the compounds of formula (I) according to any one of claims 1 to 9, and R 4 is C 1 ~C 6 alkyl) Compound.
Citation Information
Patent Citations
Herbicidal fluoromethanesulfonamides
EP3103798A1
Cyclic acylaminoperfluoroalkane sulfonanilide and derivatives
JP1982085362A
N-(tetrazol-5-yl)arylcarboxamides and N-(triazol-5-yl)arylcarboxamides and their use as herbicides
JP2013536817A
N-(tetrazol-5-yl)arylcarboxamides and N-(triazol-5-yl)arylcarboxamides and their use as herbicides
JP2014521676A